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Abstract
Background
Brisk walking in older people can increase step-counts and moderate to vigorous intensity
physical activity (MVPA) in10-minute bouts, as advised in World Health Organization
guidelines. Previous interventions have reported step-count increases, but not change in
objectively measured MVPA in older people. We assessed whether a primary care nurse-
delivered complex intervention increased objectively measured step-counts and MVPA.
Methods and Findings
A total of 988 60–75 year olds, able to increase walking and randomly selected from three
UK family practices, were invited to participate in a parallel two-arm cluster randomised trial;
randomisation was by household. Two-hundred-ninety-eight people from 250 households
were randomised between 2011 and 2012; 150 individuals to the intervention group, 148 to
the usual care control group. Intervention participants received four primary care nurse
physical activity (PA) consultations over 3 months, incorporating behaviour change tech-
niques, pedometer step-count and accelerometer PA intensity feedback, and an individual
PA diary and plan. Assessors were not blinded to group status, but statistical analyses were
conducted blind. The primary outcome was change in accelerometry assessed average
daily step-counts between baseline and 3 months, with change at 12 months a secondary
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outcome. Other secondary outcomes were change from baseline in time in MVPA weekly in
10-minute bouts, accelerometer counts, and counts/minute at 3 months and 12 months.
Other outcomes were adverse events, anthropometric measures, mood, and pain. Qualita-
tive evaluations of intervention participants and practice nurses assessed the intervention’s
acceptability. At 3 months, eight participants had withdrawn or were lost to follow-up, 280
(94%) individuals provided primary outcome data. At 3 months changes in both average
daily step-counts and weekly MVPA in10-minute bouts were significantly higher in the in-
tervention than control group: by 1,037 (95% CI 513–1,560) steps/day and 63 (95% CI 40–
87) minutes/week, respectively. At 12 months corresponding differences were 609 (95% CI
104–1,115) steps/day and 40 (95% CI 17–63) minutes/week. Counts and counts/minute
showed similar effects to steps and MVPA. Adverse events, anthropometry, mood, and
pain were similar in the two groups. Participants and practice nurses found the intervention
acceptable and enjoyable.
Conclusions
The PACE-Lift trial increased both step-counts and objectively measured MVPA in10-
minute bouts in 60–75 year olds at 3 and 12 months, with no effect on adverse events. To
our knowledge, this is the first trial in this age group to demonstrate objective MVPA in-
creases and highlights the value of individualised support incorporating objective PA as-
sessment in a primary care setting.
Trial Registration
Controlled-Trials.com ISRCTN42122561
Introduction
Physical activity (PA) is an important determinant of health and well-being in older people
and reduces mortality [1]. Older adults are advised to be active daily and to accumulate at least
150 minutes of moderate to vigorous intensity PA (MVPA) weekly, in at least 10 minute bouts.
This can be achieved through regular walking [1,2]. Recent surveys based on objective PA as-
sessment suggest that less than 5% of this age group achieve recommended PA levels [3,4].
Increasing older people’s PA is challenging. Behaviour change techniques (BCTs) (e.g.,
goal-setting, self-monitoring, building self-efficacy) are more effective than health education
alone [5]. Best practice includes gradually increasing to moderate intensity, incorporating PA
into daily routines (e.g., walking) and monitoring intensity [5]. Interventions tailored to peo-
ple’s needs and delivered at the individual or household level can encourage walking [6]. Pri-
mary care provides an ideal context for PA interventions; it allows population-based sampling
of healthy older people (by individual or household), practice nurse involvement, and continui-
ty of care, with many chronic diseases being indicators for increasing PA. United Kingdom Na-
tional Health Service (NHS) Health Checks include adults to age 74 and incorporate brief
advice on increasing PA, often by practice nurses or health care assistants [7].
Pedometers provide direct step-count feedback; accelerometers need computer analysis, but
record step-counts and PA intensity. Three systematic reviews found pedometer users in-
creased steps/day by 2,000–2,500, but trials included few older adults and focused on
PACE-Lift Cluster Randomised Controlled Trial
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volunteers or patients with specific conditions, mainly with short follow-up (3 to 6 months)
[8–10]. Two more recent older adult population-based primary care trials showed significant
step-count increases at 3 [11,12] and 6 months [12], but did not report on MVPA and included
few men [11,12].
We therefore conducted a randomised trial to determine whether an intervention based on
pedometer and accelerometer feedback combined with practice nurse PA consultations in-
creases PA levels in 60–75 year olds over 3 months and whether any change is maintained at
12 months. Secondary aims were to assess whether effects were modified by age, gender, body
mass index (BMI), disability, exercise self-efficacy or taking part as a couple, and to estimate ef-
fects on patient reported outcomes and anthropometric measures. The trial was designed to be
population-based and to measure objectively assessed PA, including MVPA (providing a direct
link to PA guidelines). Qualitative studies were undertaken with intervention participants and
practice nurses to assess the intervention’s acceptability and the barriers and facilitators to in-
creasing PA.
Methods
Trial Design
The trial protocol has been published (S1 Text) [13]. A two-arm parallel cluster randomised
trial, randomised by household, compared a complex intervention to increase walking carried
out over a 3 month period with a usual care control group. The primary endpoint was assessed
at 3 months. Further follow-up assessed maintenance of any differences between groups at
12 months.
Ethical Review
The trial was approved by Oxfordshire Research Ethics Committee C, UK (11/H0606/2).
Participants
Eligible participants were patients aged 60–74 years registered at three general practices in Ox-
fordshire and Berkshire, UK, who could walk outside and had no contra-indications to increas-
ing PA. Patients were excluded if they were in a residential or nursing home or were identified
as having a medical or psychiatric condition unsuitable for the intervention either through
Read code from their electronic primary care records or by their general practitioner (family
practice doctor) prior to invitation mail-out (S1 Text) [13]. A random sample of 200 eligible
households, with either one or two older adults at the same address, was selected per practice.
Individuals in these households were mailed an invitation and a reminder if no response was
received after 6 weeks. Further households were randomly selected until 100 individuals per
practice were randomised.
Baseline Assessment Procedures
Interested patients attended a baseline assessment at the practice, where individual informed
written consent was obtained. Two eligible people in a household were invited together (apart
if preferred). Recruitment was between October 2011 and September 2012. The baseline ques-
tionnaire, which assessed a range of health and lifestyle factors, was administered, and height,
weight, and fat mass measured (S1 Text) [13]. Participants were asked to continue with their
usual PA while wearing a hip-mounted accelerometer (GT3X+, Actigraph LLC) to record PA
(in 5 s epochs) all day (between rising and going to bed) for 7 consecutive days, except for bath-
ing, and to keep a contemporaneous PA diary. Accelerometers and diaries were returned to the
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practice. Participants not providing5 days of540 minutes (9 hours) per day of data were
asked to rewear the accelerometer.
Randomisation and Masking
Participants with adequate baseline accelerometer data were randomised using the Nottingham
Clinical Trials Unit internet randomisation service. Randomisation was at household level to
avoid couple contamination. Block randomisation was used within practice with random sized
blocks, varying between 4 and 6, and 1:1 allocation ratio, to ensure group balance and an even
nurse workload. Participants were informed by telephone of their group allocation. Researchers
were not blind to intervention status at assessments.
Procedure for the Control Group
Control group participants received usual care from the general practice, with no trial contacts
other than for data collection at baseline, 3 months, and 12 months.
Procedure for the Intervention Group
The researcher arranged a first nurse appointment for participants (either as an individual or
as a couple). The practice nurse arranged the three further appointments for participants,
which were 2, 6, and 10 weeks later. The main focus of the intervention was the four individual-
ly tailored PA consultations with the practice nurse. Data collection for trial outcomes was as
for the control group at 3 months and 12 months.
Complex Intervention Components
The components of the intervention are summarised in Table 1 and have been described previ-
ously (S1 Text) [13]. The key components were as follows: (i) pedometers (SW-200, Yamax
Digi-Walker) given to participants by nurses at their first visit to record their step-counts in
the PA diary; (ii) accelerometers (GT3X+, Actigraph) that participants were asked to wear be-
fore the second, third, and fourth nurse visits and from which nurses downloaded data during
the consultation to show participants the time they were spending in different PA intensities;
(iii) practice nurse consultations based on key BCTs including goal-setting, self-monitoring,
building self-efficacy and social support, overcoming barriers, preventing relapses, and build-
ing lasting habits; (iv) PACE-Lift patient handbook, which supported BCTs, given to patients
to keep at their first appointment and used during consultations; (v) individual walking/PA
plan agreed upon during consultations between nurses and participants to encourge adding in
both steps and time spent walking in moderate intensity PA, in bouts of at least 10 minutes, to
each individual’s baseline; (vi) PA diary to record PA and step-counts, used with the monitors
to set goals, monitor progress, and aid feedback, by relating specific diary activities to acceler-
ometer recorded PA intensities.
3 Month Assessment and Outcome Measures
The researcher arranged a 3 month outcome assessment, conducted as per baseline, at the par-
ticipant’s practice, including wearing the accelerometer for a further 7 days, for both groups.
The primary outcome was change in average daily step-count between baseline and 3 months.
The secondary outcomes were changes in average weekly time spent in MVPA, MVPA in>10
minute bouts, and in accelerometer counts and counts/minute of wear-time between baseline
and 3 months. All primary and secondary outcomes were assessed by accelerometry. Ancillary
outcomes were changes in depression (15-item Geriatric Depression Score), anxiety (4-item
PACE-Lift Cluster Randomised Controlled Trial
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FEAR score), and pain (4-item self-reported pain score) (see protocol [S1 Text] for full refer-
ences for all questionnaire measures [13]), BMI, and percentage body fat. Adverse events were
collated from contemporaneous spontaneous patient reports to nurses or researchers for trial
safety purposes. Adverse events were also collected retrospectively from questionnaires in a
systematic manner for control and intervention participants at 3 months for trial outcome re-
porting. Questions covered falls inside and outside the house, fractures, sprains or injuries, and
deterioration in health problems.
12 Month Assessment
The 12 month assessment was based on postal accelerometry and questionnaires, similar to
those for the 3 month assessment. No anthropometric measurements were made.
Data Reduction
ActiGraph data were reduced using Actilife software (v6.6.0) set to ignore runs of60 minutes
of zero counts [4,13]. We used axis 1 counts as these are the basis of the validated step and
MVPA algorithms. The analysis summary variables were: steps; accelerometer wear-time; total
daily counts, counts per minute of wear-time (CPM); time spent in MVPA (1,952 CPM,3
METs) using standard Freedson cut-points [14]; and time spent in10-min bouts of MVPA.
Table 1. Components of the complex intervention for the PACE-Lift trial.
Components What Was Provided Additional Detail on Components
Pedometer Yamax Digi-Walker SW-200 model Nurse gave to patient at ﬁrst visit with instructions for use. Provided
direct step-count to participants and required daily manual recording
and re-setting. Asked participants to wear for 7 days before
subsequent nurse visits and to record step-counts in PA diary. Could
wear more often if they wished.
Accelerometer Actigraph GT3X+ (LLC) Asked participants to wear for 7 days before second, third, and fourth
nurse visits. Recorded time spent in different PA intensities (sedentary,
light, moderate, vigorous) [13]. The nurse downloaded data to a
computer and provided visual feedback to participants at each visit.
Practice nurse PA
consultations
Four individually tailored PA consultations with the
practice nurse. Participants could be seen individually
or as a couple.
PA consultations with a practice nurse based on BCTs. Session timing,
content, and proposed BCTs are fully described elsewhere [13].
Pedometers, accelerometers, walking plan, and step-count diaries
were planned as useful adjuncts to BCTs.
Patient handbook Patient handbook to support 12-week walking
programme
PACE-Lift patient handbook, including BCTs, adapted from the NHS
Health Trainer Handbook but focusing only on PA behaviour change,
was produced for the trial, used for nurse training and by nurses during
their consultations and given to individual patients to keep at their ﬁrst
appointment. (See protocol for details [13].)
Walking/PA plan Individual walking/PA plan An individual walking /PA plan, devised during nurse PA consultations.
We did not use a single goal (e.g., 10,000 steps/day) but instead
nurses encouraged steps and time spent walking in moderate intensity
PA, particularly in bouts of at least 10 minutes, to be added
incrementally to each individual’s baseline. Nurses also encouraged
discussion of when participants would walk, where, and who with.
PA diary PA diary to record weekly PA for 12 weeks (step-count
and walks)
A diary to record PA and step-counts, used with the monitors, to set
goals, monitor progress, and aid feedback by relating speciﬁc diary
activities to accelerometer recorded PA intensities.
The PACE-Lift patient handbook and PA diary are available in S3 and S4 Texts. Practice nurse training, supervision, support, and methods for ensuring
intervention ﬁdelity have been described previously (S1 Text) [13].
doi:10.1371/journal.pmed.1001783.t001
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Accelerometer counts are a dimensionless number that quantify the amplitude and frequency
of the acceleration signal; they are brand specific.
Changes from Planned Analysis in Protocol
Patients were aged 60–74 years when they were selected; however, some were aged 75 at rando-
misation, therefore the primary aim now relates to 60–75 year olds. The protocol stated that
patients should have5 days of600 minutes recorded activity to be randomised; 24 patients
were randomised not meeting this criteria. The criteria for “adequate” wear-time varies, but re-
searchers generally use criteria of a minimum of 3–5 days of data [15], with either 600 [16] or
480 [17] minutes/day of data. Prior to data unblinding, and agreed by the Trial Steering Com-
mittee, the criteria was relaxed to allow days of540 minutes of data to be included, minimis-
ing missing days, whilst maximising the likelihood that the data included in analyses accurately
reflected activity for the day measured. Thus patients were considered correctly randomised if
they had5 days with540 minutes of data/day. Twelve people were incorrectly randomised
(i.e., with<540 minutes data on 5 days) (Fig. 1) as incomplete baseline assessment. At 3 and 12
months, analysis includes any day with540 minutes, to lessen attrition bias.
Statistical Power and Analyses
A sample of 300 individuals was required to detect a difference of 850 steps/day at 3 months
between the two groups with 90% power, 1% significance, and allowing for household cluster-
ing and 10% attrition [13]. Analysis and reporting followed CONSORT guidelines [18]. Statis-
tical analyses were carried out blind to study group.
Analysis of Outcomes
Our primary analysis was based on analyzing all participants with1 day of 540 minutes
wear-time at 3 months. We fitted a multi-level model in STATA using the xtmixed procedure.
Level 1 was day within individual, level 2 was individual, and level 3 household. The multi-
level model used assumed the random effects were independent and the model was fitted
using maximum likelihood. Number of steps on a given day at 3 months was regressed on day
order of wear, day of week, month of baseline accelerometery, age, gender, practice, treatment
group, and estimated average daily steps at baseline. By including baseline daily steps as a co-
variate, this effectively measured change in step-count over the 3 months, minimising bias
and maintaining power [19,20]. Estimated average daily steps at baseline was derived by using
a similar two-level model in which daily steps were regressed on day order of wear and day of
week. Secondary outcome measures were number of minutes spent in MVPA and MVPA in
bouts of 10 minutes, as well as counts and counts per minute. These measures were highly
correlated with step-count and were analysed using identical approaches. In all presentations
MVPA is expressed as estimated number of minutes spent in MVPA (or MVPA in10-min-
ute bouts) per week. Checks were carried out to confirm that the distribution of residuals
from the regression models for change in steps and MVPA were normally distributed (S1 and
S2 Figs.).
Ancillary Variables
The effects of the intervention on change in depression, anxiety and pain scores, BMI, and
body fat were estimated using a two-level model in which outcome was regressed on the same
measure at baseline, practice, month of baseline treatment, age, gender, and treatment. Level 1
was individual, level 2 household.
PACE-Lift Cluster Randomised Controlled Trial
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Fig 1. PACE-Lift CONSORT diagram.
doi:10.1371/journal.pmed.1001783.g001
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Adverse Events
Numbers who suffered adverse events between 0 and 3 months (spontaneously reported or sys-
tematically collected from the 3 month questionnaire) were compared between groups using
Fisher’s exact test.
Subgroup Analyses
For the primary outcome only, interaction terms were added to the regression model to test
whether the intervention effect varied between: men and women; different age groups; different
BMI cut-offs; different disability levels; different levels of confidence in ability to exercise; and
those taking part as a couple versus those taking part individually.
Sensitivity Analyses
The primary analysis, while statistically efficient, gives greater weight to participants recording
more valid days of accelerometry at 3 months. To assess the effect of this, average daily step-
counts at 3 months were estimated in the same way as average baseline steps. The 3 month av-
erage daily step-count was regressed on baseline average daily step-count in a two-level model
as for other outcome variables to assess the treatment effect, thus giving equal weight to each
participant in the analysis. To assess if participants lost to follow-up, or who failed to record a
single adequate day at 3 months, might have introduced bias, we used the STATA procedure
mi impute to impute average steps/day at 3 months based on baseline steps, gender, age, month
of baseline accelerometry, practice, and treatment group. Further analyses added postcode de-
rived Index of Multiple Deprivation (IMD) score [21] as national quintiles, self-reported pain,
and fat mass to the imputation. Sensitivity analyses also explored the possible impact of out-
comes not being missing at random. We assumed that control participants with missing data
experienced no change. In the treatment group we explored scenarios of no change and ±3,000
steps at 3 months and ±1,500 steps at 12 months. Finally, sensitivity analyses were performed
repeating the main analyses using the original criteria of600 minutes/day wear-time.
We repeated the primary analyses and assessment of adverse events at 12 months.
Qualitative Evaluations with Intervention Participants and Practice
Nurses
We examined the experiences of participants who did and did not increase their walking in
order to determine the acceptability of the intervention and the barriers and facilitators to PA
for trial participants. An experienced qualitative interviewer (AR) conducted 30 semi-struc-
tured telephone interviews, using a topic guide, with a purposive sample of 19 participants who
had increased their walking at 3 months and maintained this at 12 months (improvers) and 11
participants who had not (non-improvers). Interviews were audio-recorded, transcribed, and
coded independently by researchers to generate a thematic coding framework.
We explored the practice nurses’ evaluation of the acceptability of the intervention in a
group interview with four practice nurses who had delivered the intervention (two at one prac-
tice, one at each of the other practices) facilitated by experienced qualitative researchers (CRV,
AW) using a semi-structured interview guide. The interview was audio-recorded, transcribed,
and coded independently.
PACE-Lift Cluster Randomised Controlled Trial
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Results
Participants
Of 988 patients invited, 298 (30%) were randomised to intervention (n = 150) or control
(n = 148) groups (Fig. 1). Six participants withdrew and two were lost to follow-up (unable to be
contacted) at 3 months (8/298, 3%). A total of 280/298 (94%) provided accelerometer data with
at least 1 day of540 minutes wear-time and were included in the primary outcome analysis at
3 months. Of these, 135/138 (98%) patients in the control group and 140/142 (99%) individuals
in the intervention group provided3 days of540 minutes wear-time data (S1 Table). At
12 months, 15 patients had withdrawn, two were lost to follow-up, and one had died (18/298,
6.0%). Baseline characteristics were similar between randomised groups except that participants
in the intervention group were on average slightly older than those in the control group, more
likely to have left school younger, be overweight or obese, more likely to have chronic diseases
and disability, and a slightly lower baseline step-count (Table 2). Over 70% of both groups
(104/148 parcipants in control group and 114/150 parcipants in intervention group) were from
the least deprived national quintile of Index of Multiple Deprivation (IMD) [21] Accelerometer
wear-time was similar in the control and intervention groups at baseline (Table 2).
Among intervention participants, 129/150 (86%) attended all four nurse sessions. Partici-
pants were asked to wear an accelerometer for the week before sessions 2–4; this occurred be-
fore 98% (415/425) of nurse sessions attended.
Effect of the intervention on PA at 3 and 12 months. Average daily step-count increased
at 3 months in the intervention group and decreased in the control group; the between-group
difference in change was 1,037 (95% CI 513–1,560) steps/day (p< 0.001) (Table 3). All coeffi-
cients from the model fitted are given in S2 Table. Time spent in MVPA followed the same pat-
tern; the between-group difference was 66 (95% CI 36–96) minutes/week (p< 0.001). Of this
number, the difference in10 minute bouts of MVPA was 63 (95% CI 40–87) minutes/week
(p< 0.001). At 12 months the corresponding differences were 609 (95% CI 104–1,115) steps/
day (p = 0.018) and 40 (95% CI 10–70) minutes/week MVPA (p = 0.009); all of the increased
MVPA was in10 minute bouts 40 (95% CI 17–63) (p = 0.001) (Table 3). Both counts and
counts per minute of wear-time exhibited similar patterns to the steps and MVPA findings,
with highly significant intervention effects at 3 months; at 12 months counts, but not counts
per minute of wear-time, were statistically significant (Table 3).
Subgroup Analyses
None of the potential effect modifiers examined (age, gender, taking part as a couple, BMI, ex-
ercise self-efficacy, disability) were statistically significant (Fig. 2). However, there was a sugges-
tion that the treatment effect could be larger for men 1,534 (95% CI 775–2,294) than women
591 (95% CI −125 to 1,307) (p = 0.08) and stronger for couples 1,750 (95% CI 850–2,651) than
individuals 692 (95% CI 64–1,319) (p = 0.06).
Effect of the intervention on other health related outcomes. There were no between-group
differences in change in BMI, 0.001 kg/m2 (95% CI −0.17 to 0.18) (p = 0.98), or in change in fat
mass, 0.39 kg (95% CI −0.85 to 0.07) (p = 0.10), at 3 months (Table 4). There were no between-
group differences in mean scores of depression, anxiety, or pain at 3 or 12 months (Table 4).
Effect of the Intervention on Adverse Events
Questionnaire systematically reported adverse events (both total number and individual types)
were similar between the groups; intervention-control difference of total questionnaire adverse
events −4% (95% CI −15 to 7) (p = 0.48) and −1.0% (95% CI −13 to 11) (p = 0.90) at 3 and 12
PACE-Lift Cluster Randomised Controlled Trial
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Table 2. Baseline characteristics of 298 randomised participants.
Characteristic Control Group, n = 148 Intervention Group, n = 150
n (%) n (%)
Age at randomisation
60–64 years 69 (47) 41 (27)
65–69 years 44 (30) 61 (41)
70–75 years 35 (24) 48 (32)
Gender: male 69 (47) 69 (46)
Marital status
Married 117 (80) 123 (82)
Widowed 9 (6) 12 (8)
Divorced or separated 14 (10) 10 (7)
Single 7 (5) 5 (3)
Retired 80 (55) 95 (63)
Ethnicity: white 143 (98) 147 (99)
Age ﬁnished full-time education
16 54 (37) 67 (46)
17–18 20 (14) 25 (17)
19+ 71 (49) 55 (37)
National quintiles of Index of Multiple Deprivation Ranka
1–3 (most deprived) 16 (11) 13 (9)
4 28 (19) 23 (15)
5 (least deprived) 104 (70) 114 (76)
Current smoker 10 (7) 6 (4)
General healthb: very good or good 133 (92) 127 (86)
Chronic diseasesb
None 52 (35) 39 (26)
1–2 84 (57) 94 (63)
3 12 (8) 17 (11)
Presence of self-reported painb 100 (68) 101 (68)
Limiting long-standing illnessb 32 (23) 40 (28)
FRATb (0–5)
Low risk, score 0 92 (64) 98 (66)
Medium risk, score 1–2 48 (33) 44 (30)
High risk, score 3+ 4 (3) 6 (4)
Geriatric Depression Scoreb (0–15): high (5) 11 (8) 7 (5)
Fear anxiety scoreb (0–4): high (2–4) 22 (15) 22 (15)
Townsend disability scoreb
None (0) 111 (76) 93 (63)
Mild disability (1–5) 31 (21) 51 (35)
Moderate or severe disability (6–18) 4 (3) 3 (2)
Low self-efﬁcacy scoreb 34 (24) 37 (26)
Receiving occupational pension 105 (74) 109 (77)
Difﬁculty in paying billsb: ever 15 (10) 17 (12)
Randomised as a couple 47 (32) 52 (35)
Season of baseline measure
March–May 40 (27) 29 (19)
June–August 39 (26) 48 (32)
(Continued)
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months, respectively (Table 5). Spontaneously reported events were less common compared
with questionnaire reported events and they were non-significantly higher in the intervention
group than the control group at 3 months (5% [95% CI −0.3% to 11] [p = 0.09]) and 12 months
(7% [95% CI −0.6 to 14] [p = 0.09]) (Table 5). The total of any adverse events reported on the
questionnaire or spontaneously was similar between the groups, intervention-control differ-
ence −2% (95% CI −13 to 9) (p = 0.78) and 1% (95% CI −11 to 13) (p = 0.90) at 3 and
12 months, respectively.
Sensitivity analyses. In analyses giving equal weight to each participant (irrespective of the
number of days of PA data), the estimated treatment effect of 1,041 (95% CI 519–1,563) steps/
day (p< 0.001) was almost identical to that in our primary analysis (S3 Table). Imputation as-
suming participants with missing data were missing at random also made little difference.
Even assuming extreme differences in intervention and control participants with missing data
did not alter the broad conclusions (S3 Table).
Analyses using a wear-time criteria of600 minutes/day produced similar results to the
540 minute cut-off (S4 Table): at 3 months, 995 (95% CI 456–1,535) steps/day (p< 0.001),
66 (95% CI 42–89) minutes/week in10 minute bouts (p< 0.001); and at 12 months, 599
(95% CI 70–1,128) steps/day (p = 0.026) and 40 (95% CI 16–64) minutes/week in10 minute
bouts (p = 0.001).
Qualitative Evaluations
Acceptability for trial participants. Both improvers and non-improvers were very positive
about most intervention components. This perspective included using the pedometers “it was
Table 2. (Continued)
Characteristic Control Group, n = 148 Intervention Group, n = 150
n (%) n (%)
September–November 38 (26) 41 (27)
December–February 31 (21) 32 (21)
Physical characteristics
BMI: overweight/obese (25kg/m2) 92 (62) 108 (72)
Mean (SD) Mean (SD)
Fat massc (kg) 23.2 (9.7) 24.5 (8.5)
Waist circumferencec (cm) 95.2 (14.1) 96.5 (11.2)
Accelerometry datac
Adjusted baseline step count per day 7,380 (2,988) 7,314 (2,693)
MVPA
Total weekly minutes 301 (169) 296 (154)
Total weekly minutes in 10 minute bouts 88 (113) 96 (104)
Adjusted baseline counts per day 246,610 (111,809) 244,225 (94,980)
Adjusted baseline counts per minute of wear-time 310 (129) 306 (112)
Adjusted average daily wear-time (minutes) 789 (72) 797 (79)
aNational quintiles of Index of Multiple Deprivation rank [21].
bFull references for general health, chronic disease score, limiting long-standing illness, self-reported pain, Falls Risk Assessment Tool (FRAT), Geriatric
Depression Score (GDS-15), FEAR anxiety score, Townsend Disability Score, Self-Efﬁcacy Score, difﬁculty in paying bills, are given in the trial protocol
[13].
cFor fat mass, waist circumference, and all accelerometry data, numbers presented are mean (standard deviation [SD]).
doi:10.1371/journal.pmed.1001783.t002
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quite a revelation. . ..quite fun actually” (participant 18, female, improver, aged 63), accelerom-
eter feedback on PA intensity “the graph was particularly good, I was very interested to see that”
(participant 5, female, non-improver aged 75), and seeing the nurse “the support of the
nurse. . ..it was very good. . ..she brought positive things forward” (participant 1, male, non-
improver, aged 67). The handbook had a more mixed reception: some who had increased their
walking found it valuable “the handbook was very helpful, I did fill it in and it made me think
about it and what I wanted to achieve” (participant 15, female, aged 69); whilst others who had
not increased walking were sometimes critical “American managementese garbage” (participant
2, male, aged 67). Those who had increased their walking made positive comments about the
programme overall “. . . the whole PACE-Lift thing . . . it’s had an effect on my life and I’m fitter
for it” (participant 26, male, aged 68) and “how much I now enjoy walking, just for its own sake,
which I wouldn’t have said a year ago” (participant 27, male, aged 67).
Acceptability for practice nurses. The nurses were all enthusiastic about the intervention,
including the monitors: “the equipment was excellent, the pedometers, the accelerometers, excel-
lent, excellent . . .” (Nurse C); the feedback on PA intensity “they love the diary, working out
what they were doing at that time and the graph, didn’t they?” (Nurse C); and the time
they spent with participants “to give them the quality of time that they have been given in this
trial . . .” (Nurse B). Of particular value to them was the BCT training “that really helped me to
listen and ask open questions . . . we’re using it, I’ve changed my nursing practice through it”
(Nurse A); “to communicate with patients, actually figure out what their agenda is and help
them achieve their goals” (Nurse D).
Barriers and facilitators to PA. All participants talked about the different intervention ele-
ments (use of pedometer and accelerometers; the handbooks and diaries; the nurse consulta-
tion; the individualised goal setting and developing strategies for the future). The differences
between our two groups were in the perception of these as enablers (or barriers) to increasing
walking. Improvers were more positive about the use of the pedometer: “well I think we were
motivated because we had. . . little pace . . . step counters, you know on our side, and so of course
Table 3. Treatment effect for primary and secondary outcome measures.
Outcome Measure Control Group (Mean [SD]) Intervention Group (Mean [SD]) Treatment Effect at 3
Monthsa
Treatment Effect at 12
Monthsa
Baseline 3 Months 12 Months Baseline 3 Months 12 Months Effect 95% CI p-Value Effect 95% CI p-Value
n 148 138 136 150 142 137 280 273
Daily step count 7,380
(2,988)
6,904
(3,061)
6,872
(2,792)
7,314
(2,693)
7,903
(3,194)
7,514
(3,165)
1,037 (513–
1,560)
<0.001 609 (104–
1,115)
0.018
MVPA: Total weekly
minutes
301 (169) 278 (169) 285 (174) 296 (154) 333 (185) 319 (188) 66 (36–96) <0.001 40 (10–70) 0.009
MVPA: Total weekly
minutes in 10
minute bouts
88 (113) 72 (102) 75 (108) 96 (104) 134 (138) 118 (130) 63 (40–87) <0.001 40 (17–63) 0.001
Daily counts 246,610
(111,809)
231,278
(110,870)
239,158
(114,776)
244,225
(94,980)
266,357
(119,648)
257,511
(117,882)
40,459 (21,483–
59,436)
<0.001 21,436 (2,207–
40,665)
0.029
Counts per minute of
wear-time
310 (129) 295 (127) 304 (136) 306 (112) 333 (140) 322 (139) 48 (25–70) <0.001 23 (−0.7 to
46)
0.057
All accelerometry data are adjusted for day of the week and day order of wearing the accelerometer with participant as a random effect in a multi-
level model.
aThe treatment effect is the difference between groups (intervention − control) in change from baseline at 3 months and 12 months. The changes at 3 and
12 months are adjusted for baseline measure, practice, age, gender, month of baseline accelerometry, day of the week, and day order of wearing the
accelerometer in a multi-level model with household and participant as random effects.
doi:10.1371/journal.pmed.1001783.t003
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we kept checking to make sure that you tried to achieve the. . . steps a day, and we sort of kept
motivated” (participant 13, female, aged 67); individualised goal setting and monitoring “she
was just very very positive. If we’d had a bad week or whatever, you know, it had gone down
from the week before, she just said “Well look how well you’re doing!” (participant 28, female,
Fig 2. Treatment effect by subgroup at 3 months.
doi:10.1371/journal.pmed.1001783.g002
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improver, aged 62); the appropriateness of walking as a form of PA for people of “their age”
“Walking certainly, because I mean . . . at my age, umm, virtually anything else is. . . inappropri-
ate” (participant 14, male, aged 71); and in developing strategies for keeping walking in the fu-
ture “Well it’s just . . . a habit we’ve got into I suppose and we just kept going from that”
(participant 29, male, aged 73). Both groups commented upon a range of constraints to in-
creasing their walking with the weather “Well, no, just the weather” (as a limitation on walking)
(participant 7, female, non-improver, aged 71) and existing health problems “I mean I have
high blood pressure and umm . . . uhh . . . osteoporosis so, in fact, you know, the walking benefits
very much. . .” (participant 22, female, improver, aged 65). However, as that participant illus-
trated, the improvers were able to overcome these barriers and saw the consequent benefits for
other aspects of their life.
Discussion
Main Findings
In this trial, differences in both step-counts and time spent in MVPA (nearly all within bouts
of10 minutes) were observed between the intervention group compared with the control
group at 3 months and at 12 months. No effect was seen on other health outcomes, including
adverse events. The intervention was well accepted, with 87% attending all four nurse sessions,
nearly all wearing the accelerometer before their appointments, and positive comments about
all aspects of the trial from participants and nurses. While the intervention itself, particularly
the use of accelerometer PA intensity feedback, was novel, the key methodological develop-
ment was the successful embedding of the intervention within primary care. Primary care pro-
vided the sampling frame, an efficient mechanism for identifying unsuitable participants,
practice nurses to deliver the intervention, and a supportive environment.
Table 4. Other outcome measures.
Outcome
Measure
Control Group (Mean [SD]) Intervention Group (Mean
[SD])
Treatment Effect at 3 Monthsa Treatment Effect at 12 Monthsa
Baseline 3
Months
12
Months
Baseline 3
Months
12
Months
Effect 95% CI p-Value Effect 95% CI p-Value
n 148 143 137 150 146 136 240–288 239–267
BMI (kg/m2) 27.1 (4.5) 26.8 (4.3) — 27.7 (4.1) 27.6 (4.1) 0.00 (−0.17 to 0.18) 0.98 —
Fat mass (kg)b 23.2 (9.7) 23.1 (9.7) — 24.5 (8.5) 23.9 (8.6) — −0.39 (−0.85 to 0.07) 0.10 —
Geriatric
depression score
(0–14)c
1.5 (1.9) 1.4 (2.3) 1.3 (2.0) 1.3 (2.0) 1.1 (1.8) 1.1 (1.7) −0.24 (−0.58 to 0.09) 0.16 −0.23 (−0.59 to 0.14) 0.22
Fear anxiety
score (0–3)c
0.6 (0.8) 0.6 (0.8) 0.7 (0.9) 0.6 (0.8) 0.6 (0.8) 0.6 (0.9) −0.01 (−0.15 to 0.14) 0.93 −0.01 (−0.17 to 0.15) 0.94
Self−reported
pain (0–3)c
0.9 (0.8) 1.0 (0.8) 0.9 (0.8) 1.0 (0.8) 1.0 (0.8) 0.9 (0.8) 0.01 (−0.15 to 0.18) 0.86 0.04 (−0.13 to 0.20) 0.69
aThe treatment effect is the difference between groups (intervention-control) in change from baseline at 3 months and 12 months. The differences at 3 and
12 months are adjusted for baseline measure, practice, age, gender, and month of baseline accelerometry in a multi-level model with household as a
random effect.
bFat mass was missing for six and three participants in the control group and for ﬁve and seven participants in the intervention group at baseline and 3
months, respectively.
cGeriatric depression scores, fear anxiety scores, and self-reported pain were missing for varying numbers of participants (maximum 15) at each time-
point.
doi:10.1371/journal.pmed.1001783.t004
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Strengths andWeaknesses of This Study
To our knowledge, this study is the largest reported pedometer-based walking intervention for
older people, recruiting from a population-based sample and with a high recruitment rate of
30%, higher than other primary care PA trials [22,23] and over 90% retention rate at 12 months.
Detailed sensitivity analyses demonstrated the effect estimates were robust. Around half of par-
ticipants were men, often under-represented in trials [8–10], and there was a balance across
age groups. A study limitation is that whilst the intervention was effective in older men and
women from an affluent, non-ethnically diverse socio-economic area, generalisability to more
diverse populations cannot be assumed. Previously published work on those declining partici-
pation in this trial showed that participants were more likely than non-participants to live in af-
fluent postcodes [24].
The fact that the intervention group at baseline was slightly older than the control group
was consistent with their leaving full-time education younger and having slightly higher levels
of chronic illness and disability. However, our analyses were based on change, with baseline
level of PA being controlled for. Adjusting for baseline activity controls for many factors associ-
ated with activity in cross-sectional analyses. Moreover, our effect modification analyses sug-
gests no difference in the intervention by age or disability.
In the study design, nurses from the practices, rather than researchers or exercise specialists,
delivered the intervention and incorporated feedback on participants’ PA intensity from accel-
erometers to provide personalised PA goals. As the intervention involved multiple compo-
nents, we cannot identify which components were important in changing PA, although
qualitative evaluations from both participants and nurses emphasised the value of all the differ-
ent intervention elements. Whilst researchers assessing outcomes were not masked to group
status, an important study strength was that the main outcome was accelerometer PA measure-
ment, enabling change in both step-counts and PA intensity to be objectively assessed. Waist-
worn accelerometers measure walking accurately, while self-reported PA, particularly walking,
is prone to recall bias [25]. One potential criticism in using monitors to assess PA is that partic-
ipants might try harder when being monitored. However, any Hawthorne effect would have
Table 5. Adverse events.
Adverse Event 0–3 Months 0–12 Months
Control (C) Intervention
(I)
Difference Control (C) Intervention
(I)
Difference
n/N (%) n/N % I − C 95% CI p-Value n/N % n/N % I − C 95% CI p-Value
Any adverse event reported
on questionnaire
35/128 (27) 30/129 (23) −4% (−15 to 7) 0.48 70/127 (55) 66/122 (54) −1% (−13 to 11) 0.90
Falls inside the house 1/137 (0.7) 6/138 (4) 4% (−0.4 to 8) 0.12 8/130 (6) 15/126 (12) 6% (−1 to 13) 0.13
Falls outside the house 7/136 (5) 9/135 (7) 2% (−4 to 8) 0.62 23/134 (17) 26/125 (21) 4% (−6 to 13) 0.53
Fractures 2/130 (2) 4/131 (3) 2% (−3 to 6) 0.68 4/125 (3) 5/117 (4) 1% (−4 to 7) 0.74
Sprains or injuries 16/133 (12) 14/133 (11) −2% (−9 to 6) 0.85 30/125 (24) 32/123 (26) 2% (−9 to 13) 0.77
Deterioration in health problems already
present, since start of study
16/136 (12) 13/136 (10) −2% (−10 to 5) 0.70 32/130 (25) 34/127 (27) 2% (−8 to 13) 0.78
Adverse event reported
spontaneously
5/143 (3) 13/146 (9) 5% (−0.3 to 11) 0.09 11/144 (8) 21/146 (14) 7% (−0.6 to 14) 0.09
Any adverse event reported
on questionnaire or spontaneously
36/128 (28) 34/130 (26) −2% (−13 to 9) 0.78 71/128 (55) 70/124 (56) 1% (−11 to 13) 0.90
Denominators differ as not all questions were answered by all participants.
doi:10.1371/journal.pmed.1001783.t005
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been reduced by our 7-day protocol and would have affected both groups [9]. The fact that the
observed changes in the intervention group affected not only steps and MVPA but also bouts
of MVPA of at least 10 minutes, suggests that participants were making recommended changes
by increasing planned, structured walking.
A further strength is the inclusion of qualitative findings from intervention participants and
practice nurses. The devices and nurse-delivered support were generally valued by all partici-
pants regardless of changes in their levels of activity. However, this raises the issue of why some
participants engaged with the psychological techniques of goal setting and developing strate-
gies to embed activity into their lives, whilst others did not. A potential weakness may be that
we were unable to interview sufficient people, to reach saturation, and to gain a clearer picture
of the factors supporting long-term behaviour change. Understanding why and how older peo-
ple engage with increasing and maintaining changes in PA is likely to require a more complex
mixed-methods design that examines individual psycho-social factors, the wider socio-envi-
ronmental context, and other key determinants of health.
Main Results in Context of Other Literature
Our difference between groups in average daily step-count of 1,037 (95% CI 513–1,560) is con-
sistent with the PA increases reported in systematic reviews of pedometer-based interventions,
although smaller than reviews reported (2,000–2,500 steps/day) [8–10]. This finding could re-
flect the fact that PACE-Lift was population-based rather than volunteer-based and that it mea-
sured step-counts using accelerometers, whereas the above studies used pedometers; there is
no direct conversion factor [26]. A Japanese study of 68 older women showed that accelerome-
ter feedback of PA intensity helped to increase PA levels [27]. Our study confirms the feasibility
and effectiveness of accelerometer PA feedback and suggests this should be explored further.
Previous walking interventions demonstrating increased time spent in MVPA are based on
self-report [28,29]. Recent trials using accelerometery have shown reductions in sedentary time
[12] and increases in minutes spent walking [11], but have been based on very small numbers
[11,12] or on women only [11]. There is evidence that people over-report PA, particularly
walking [25], so our objective measure of an increase in weekly MVPA of 66 minutes, in a large
trial including men and women, is an important finding. In terms of public health advice to
achieve MVPA in bouts of at least 10 minutes [1], 63 of the 66 minutes weekly increase was in
10 minute bouts. Whilst subgroup differences were not statistically significant, our study was
not powered to look directly at these interaction effects and our study suggests that the possibil-
ity of the intervention being more effective in men than women and in those attending as cou-
ples should not be ruled out. The gender effect is different from that suggested previously [8],
where the effect size was greater for women; but authors urged caution owing to the lack of
data on men. To our knowledge no other pedometer studies have compared effects in couples
and individuals; household sampling enabled us to investigate this effect. We intended to sam-
ple, randomise, and provide the intervention by household cluster, but it turned out that most
clusters were represented for randomisation and treatment by single individuals, which re-
duced our power for looking directly at the interaction effect of couple versus individual. We
did not find a significant effect on anthropometric outcomes at 3 months, and we did not have
funding for face-to-face assessments to measure weight and fat mass at 12 months. A meta-
analysis of pedometer-based walking interventions and weight loss found that longer interven-
tions and those with longer follow-up had greater effects, but the average increase in step-
counts was 4,000 steps/day, which is much larger than in our study [30]. Our findings are con-
sistent with another more recent pedometer-based walking intervention, which showed an ef-
fect on step-counts, but not on anthropometric measures [29]. No significant effect of the
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intervention on depression or anxiety scores either at 3 or 12 months was found. Whilst walk-
ing interventions have reported improved mood [31], published systematic reviews did not in-
clude this measure [8–10]. Other primary care pedometer-based walking interventions have
not shown an effect on mental health [12], depression, or anxiety [11].
Whilst walking is safe [1,5], a large trial in 40–74 year old women, which promoted a single
walking target, reported significantly more falls in the walking group [28]. Our trial did not
find group differences in self-reported pain or adverse events. This finding may be due to our
individualised PA plans based on the person’s baseline and “starting-low-and-going-slow” [5].
Mutrie and colleagues required participants to have a face-to-face check with a general practi-
tioner (GP) at baseline, excluding 35% (167/461) and called for simpler, less time-consuming
screening methods [12]. Our two-stage exclusion method, initially using computerised record
Read codes and followed by GP examination of potential participant lists, excluding 15% and
9% of potential participants, respectively, was quick and easy to implement, did not require a
GP visit, and raised no safety concerns. Our trial confirmed other findings that primary care
nurses can be effective in increasing PA levels in older people [12,28,32] and provided this evi-
dence using objective PA measures. Our nurse PA consultations followed primary care exercise
prescribing guidance to chart progress, set goals, and solve problems [33]. This method fits
with pedometer-based systematic review findings, suggesting that interventions with individual
tailoring and personalised activity goals are more effective [10].
Implications for Policy and Practice
The increase in PA levels in this trial was sufficiently large to have modest but appreciable ef-
fects on risks of important chronic diseases. Based on earlier reports quantifying the strengths
of associations between PA (particularly walking) and coronary heart disease (CHD) [34] and
Type 2 diabetes [35], the 40 minute weekly difference between the groups in walking observed
at one year, if sustained, would be expected to reduce CHD risk by about 5.5% (95% CI 3.9%–
6.7%) and type 2 diabetes risk by 9.1% (95% CI 4.5%–13.5%) (see S5 Text for full details of how
risk reductions were estimated). Importantly, the reduction in risk of diabetes appears largely
independent of any impact on BMI [35].
Our study demonstrates that practice nurses can safely deliver an intervention to increase
objectively measured PA levels in older people at 3 months, with a sustained effect at 12
months. Moreover, this was an acceptable population-based intervention, with 30% uptake in
the target age group. Researchers wishing to recruit older people to PA sudies should consider
the two-stage primary care recruitment method described here, which provides a population-
based sample, estimation of recruitment rate, and generalisability, with an efficient, safe way of
excluding unsuitable patients. However, the main advantage that primary care offers is an ideal
setting for delivering PA interventions in this age group and the opportunity to integrate this
into routine care. Our intervention required four PA consultations, each longer than standard
practice nurse consultations and training for practice nurses both in using accelerometers and
in BCTs. This method has implications for primary care, in that effective delivery of interven-
tions that produce sustained objective PA increases, involving personalised activity goals and
feedback of PA intensity, requires more time, training, and support than is currently standard
in NHS Health Checks [7] or routine care.
Unanswered Questions and Future Research
Future trials need to distinguish the different aspects of PA interventions, to understand the ef-
fects of the pedometer or accelerometer separately from BCTs and support offered [9,10]. They
also need to test interventions in socio-economically diverse populations, and with older
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people who have higher levels of morbidity and disability. Inclusion of a qualitative dimension
to future trials would provide further valuable insights into how older people can embrace PA
as part of their daily lives. Robust evidence on costs and cost-effectiveness needs to be gathered
before this or similar programmes can be implemented on a larger scale in routine health care.
Following demonstration of the effectiveness of this intervention, funding was obtained for a
post hoc evaluation of costs and cost-effectiveness, using existing trial evidence, and is current-
ly in process. Increased PA at 3 months is a significant finding, but maintenance of change is
of key importance. Our findings that over 50% of the difference at 3 months was maintained at
12 months, 9 months post-intervention, is an important addition to the literature. Longer term
follow-up to evaluate the need for maintenance support is needed.
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Editors’ Summary
Background
Worldwide, people are becoming increasingly sedentary. They are sitting at desks instead
of doing manual labor; they are driving to work instead of walking; and they are participat-
ing in fewer leisure time physical activities. But the human body needs regular exercise to
stay healthy. Physical activity helps to maintain a healthy weight and prevents or delays
heart disease, type 2 diabetes, and some cancers. Moreover, physically active people feel
better and live longer than physically inactive people. The World Health Organization rec-
ommends that adults should be active daily and should do at least 150 minutes of moder-
ate- to vigorous-intensity physical activity (MVPA) every week in bouts that each last at
least 10 minutes. Moderate-intensity physical activities (for example, brisk walking) re-
quire a moderate amount of effort and noticeably increase the heart rate; vigorous-intensi-
ty physical activities (for example, running) require a large amount of effort and cause
rapid breathing and a substantial heart rate increase.
WhyWas This Study Done?
When physical activity is objectively measured using an accelerometer (a movement mon-
itor that is usually worn on the waist; unlike pedometers, which simply count the number
of steps a person takes, accelerometers record both step-counts and the intensity of physi-
cal activity), fewer than 5% of older people achieve the recommended weekly levels of
MVPA. These levels could be reached by taking regular brisk walks but how can older peo-
ple be persuaded to make such walks part of their daily lives? In this cluster randomized
controlled trial—the PACE (Pedometer Accelerometer Consultation Evaluation)-Lift trial
—the researchers assess whether an intervention to increase walking comprising pedome-
ter and accelerometer feedback combined with physical activity consultations provided by
practice nurses can lead to sustained increases in physical activity in 60–75 year olds. Clus-
ter randomized trials compare outcomes in groups of people (here, husbands and wives
living in one household) assigned through the play of chance to receive a test or a
control intervention.
What Did the Researchers Do and Find?
The researchers assigned 298 people from 250 households to receive the intervention or
usual care and determined the participants’ physical activity at baseline, 3 months, and 12
months by asking them to wear an accelerometer for 7 days. Intervention group partici-
pants received four physical activity consultations with a primary care nurse over 3
months. At the first consultation, the nurse gave each participant a pedometer to measure
step-counts, a physical activity diary in which to record their goals and progress, and the
PACE-Lift patient handbook. At each consultation, the nurse used behavior change tech-
niques (for example, goal setting) to encourage the participant to walk regularly, gave the
participant visual feedback from their accelerometer readings, and devised a personal
walking plan. Control group participants received normal care only from the practice. At 3
months and 12 months, both the average daily step-count and the weekly MVPA level had
decreased from baseline in the control group but increased in the intervention group. At 3
months, compared to the control group, the average step-count in the intervention group
was 1,037 steps/day higher and the MVPA in bouts of more than 10 minutes in the
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intervention group was 63 minutes/week higher. At 12 months, the corresponding differ-
ences were 609 steps/day and 40 minutes/week. There were no significant differences in
adverse events (for example, pain), body fat, or other measured health-related outcomes
between the groups.
What Do These Findings Mean?
These findings show that the complex intervention tested in the PACE-Lift trial increased
both step-counts and objectively measured MPVA among 60–75 year olds for at least 12
months. Importantly, all the participants and practice nurses were positive and enthusias-
tic about the intervention. Moreover, the observed increase in physical activity is estimated
to reduce the participants’ risk of heart disease and type 2 diabetes by an estimated 5.5%
and 9.1%, respectively. Further trials are needed to determine which aspects of the inter-
vention were responsible for increasing physical activity, to determine whether the inter-
vention’s effects will persist for longer than 12 months, and to test the intervention in
socio-economically diverse populations (all the PACE-Lift participants came from an af-
fluent, non-ethnically diverse area). However, these findings highlight the value of family
practices providing older individuals with individualized support that incorporates objec-
tive assessment of physical activity to help them become more physically active.
Additional Information
Please access these websites via the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001783.
• The US Centers for Disease Control and Prevention provides information on all aspects
of healthy living; its Physical Activity for Everyone web pages include guidelines for
older people, instructional videos, and personal success stories (some information in En-
glish and Spanish)
• TheWorld Health Organization provides information about physical activity and health
(in several languages); its Global Recommendations on Physical Activity for Health are
available in several languages
• The UK National Health Service information source Choices explains the benefits of
regular physical activity, provides recommendations for older people, and includes tips
for exercising and some personal stories
• MedlinePlus has links to other resources about exercise and physical fitness (in English
and Spanish)
• More information about the PACE-Lift trial protocol is available
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